Search research articles
Contact Us
Filters
Showing results (891-900 of 964) with videos related to
Page
of 97
Sort By:
Frontiers in Digital Health
|
December 29, 2025
Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancer
Heidi C Ko, Stuti Patel, Rachel E Ellsworth, et al.
Archives of General Psychiatry
|
June 6, 2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
Richard S E Keefe, Robert M Bilder, Sonia M Davis, et al.
Spanish Journal of Psychiatry and Mental Health
|
June 24, 2026
Two decades of progress in schizophrenia: evolution, current insights, and future directions
Mario Alvarez-Jimenez, Celso Arango, Benedicto Crespo-Facorro, et al.
Science (New York, N.Y.)
|
August 11, 2001
Resolving the structure of ionized helium in the intergalactic medium with the far ultraviolet spectroscopic explorer
G A Kriss, J M Shull, W Oegerle, et al.
Schizophrenia Research
|
December 16, 2011
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
Daniel C Javitt, Robert W Buchanan, Richard S E Keefe, et al.
Breast Cancer (Dove Medical Press)
|
August 28, 2024
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer
Heidi Chwan Ko, R J Seager, Sarabjot Pabla, et al.
Schizophrenia Research
|
May 3, 2016
Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study
Steven P Millard, Jane Shofer, David Braff, et al.
Schizophrenia Research
|
March 10, 2015
Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS)
Keith H Nuechterlein, Michael F Green, Monica E Calkins, et al.
Schizophrenia Research
|
February 21, 2016
Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers
William S Stone, Raquelle I Mesholam-Gately, Anthony J Giuliano, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 28, 2006
Baseline neurocognitive deficits in the CATIE schizophrenia trial
Richard S E Keefe, Robert M Bilder, Philip D Harvey, et al.
Page
of 97
Search research articles
Search
Showing results (891-900 of 964) with videos related to
Sort By:
Page
of 97
Frontiers in Digital Health
|
December 29, 2025
Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancer
Heidi C Ko, Stuti Patel, Rachel E Ellsworth, et al.
Archives of General Psychiatry
|
June 6, 2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
Richard S E Keefe, Robert M Bilder, Sonia M Davis, et al.
Spanish Journal of Psychiatry and Mental Health
|
June 24, 2026
Two decades of progress in schizophrenia: evolution, current insights, and future directions
Mario Alvarez-Jimenez, Celso Arango, Benedicto Crespo-Facorro, et al.
Science (New York, N.Y.)
|
August 11, 2001
Resolving the structure of ionized helium in the intergalactic medium with the far ultraviolet spectroscopic explorer
G A Kriss, J M Shull, W Oegerle, et al.
Schizophrenia Research
|
December 16, 2011
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
Daniel C Javitt, Robert W Buchanan, Richard S E Keefe, et al.
Breast Cancer (Dove Medical Press)
|
August 28, 2024
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer
Heidi Chwan Ko, R J Seager, Sarabjot Pabla, et al.
Schizophrenia Research
|
May 3, 2016
Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study
Steven P Millard, Jane Shofer, David Braff, et al.
Schizophrenia Research
|
March 10, 2015
Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS)
Keith H Nuechterlein, Michael F Green, Monica E Calkins, et al.
Schizophrenia Research
|
February 21, 2016
Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers
William S Stone, Raquelle I Mesholam-Gately, Anthony J Giuliano, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 28, 2006
Baseline neurocognitive deficits in the CATIE schizophrenia trial
Richard S E Keefe, Robert M Bilder, Philip D Harvey, et al.
Page
of 97